187 related articles for article (PubMed ID: 33060043)
1. Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD.
Mosca A; Crudele A; Smeriglio A; Braghini MR; Panera N; Comparcola D; Alterio A; Sartorelli MR; Tozzi G; Raponi M; Trombetta D; Alisi A
Dig Liver Dis; 2021 Sep; 53(9):1154-1158. PubMed ID: 33060043
[TBL] [Abstract][Full Text] [Related]
2. The Antioxidant Effects of Hydroxytyrosol and Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease, in a Clinical Trial: A New Treatment?
Nobili V; Alisi A; Mosca A; Crudele A; Zaffina S; Denaro M; Smeriglio A; Trombetta D
Antioxid Redox Signal; 2019 Jul; 31(2):127-133. PubMed ID: 30588836
[TBL] [Abstract][Full Text] [Related]
3. Combination Treatment with Hydroxytyrosol and Vitamin E Improves NAFLD-Related Fibrosis.
Panera N; Braghini MR; Crudele A; Smeriglio A; Bianchi M; Condorelli AG; Nobili R; Conti LA; De Stefanis C; Lioci G; Gurrado F; Comparcola D; Mosca A; Sartorelli MR; Scoppola V; Svegliati-Baroni G; Trombetta D; Alisi A
Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145170
[TBL] [Abstract][Full Text] [Related]
4. Effects of Silicon vs. Hydroxytyrosol-Enriched Restructured Pork on Liver Oxidation Status of Aged Rats Fed High-Saturated/High-Cholesterol Diets.
Santos-López JA; Garcimartín A; Merino P; López-Oliva ME; Bastida S; Benedí J; Sánchez-Muniz FJ
PLoS One; 2016; 11(1):e0147469. PubMed ID: 26807847
[TBL] [Abstract][Full Text] [Related]
5. 4-HNE Immunohistochemistry and Image Analysis for Detection of Lipid Peroxidation in Human Liver Samples Using Vitamin E Treatment in NAFLD as a Proof of Concept.
Podszun MC; Chung JY; Ylaya K; Kleiner DE; Hewitt SM; Rotman Y
J Histochem Cytochem; 2020 Sep; 68(9):635-643. PubMed ID: 32867573
[TBL] [Abstract][Full Text] [Related]
6. Ornithine Aspartate and Vitamin-E Combination Has Beneficial Effects on Cardiovascular Risk Factors in an Animal Model of Nonalcoholic Fatty Liver Disease in Rats.
de Freitas LBR; Longo L; Filippi-Chiela E; de Souza VEG; Behrens L; Pereira MHM; Leonhard LC; Zanettini G; Pinzon CE; Luchese E; Lima GJSP; Cerski CT; Uribe-Cruz C; Álvares-da-Silva MR
Biomolecules; 2022 Nov; 12(12):. PubMed ID: 36551202
[TBL] [Abstract][Full Text] [Related]
7. Vitamin E alleviates non-alcoholic fatty liver disease in phosphatidylethanolamine N-methyltransferase deficient mice.
Presa N; Clugston RD; Lingrell S; Kelly SE; Merrill AH; Jana S; Kassiri Z; Gómez-Muñoz A; Vance DE; Jacobs RL; van der Veen JN
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):14-25. PubMed ID: 30300671
[TBL] [Abstract][Full Text] [Related]
8. Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients.
Paredes-Turrubiarte G; González-Chávez A; Pérez-Tamayo R; Salazar-Vázquez BY; Hernández VS; Garibay-Nieto N; Fragoso JM; Escobedo G
Clin Exp Med; 2016 May; 16(2):193-202. PubMed ID: 25894568
[TBL] [Abstract][Full Text] [Related]
9. The effect of alpha-lipoic acid on inflammatory markers and body composition in obese patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial.
Hosseinpour-Arjmand S; Amirkhizi F; Ebrahimi-Mameghani M
J Clin Pharm Ther; 2019 Apr; 44(2):258-267. PubMed ID: 30585337
[TBL] [Abstract][Full Text] [Related]
10. Role of the PNPLA3 polymorphism rs738409 on silymarin + vitamin E response in subjects with non-alcoholic fatty liver disease.
Aller R; Laserna C; Rojo MÁ; Mora N; García Sánchez C; Pina M; Sigüenza R; Durà M; Primo D; Izaola O; de Luis D
Rev Esp Enferm Dig; 2018 Oct; 110(10):634-640. PubMed ID: 30032630
[TBL] [Abstract][Full Text] [Related]
11. Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial.
Sharifi N; Amani R; Hajiani E; Cheraghian B
Endocrine; 2014 Sep; 47(1):70-80. PubMed ID: 24968737
[TBL] [Abstract][Full Text] [Related]
12. Vitamin E treatment in NAFLD patients demonstrates that oxidative stress drives steatosis through upregulation of de-novo lipogenesis.
Podszun MC; Alawad AS; Lingala S; Morris N; Huang WA; Yang S; Schoenfeld M; Rolt A; Ouwerkerk R; Valdez K; Umarova R; Ma Y; Fatima SZ; Lin DD; Mahajan LS; Samala N; Violet PC; Levine M; Shamburek R; Gharib AM; Kleiner DE; Garraffo HM; Cai H; Walter PJ; Rotman Y
Redox Biol; 2020 Oct; 37():101710. PubMed ID: 32920226
[TBL] [Abstract][Full Text] [Related]
13. Molecular adaptations underlying the beneficial effects of hydroxytyrosol in the pathogenic alterations induced by a high-fat diet in mouse liver: PPAR-α and Nrf2 activation, and NF-κB down-regulation.
Valenzuela R; Illesca P; Echeverría F; Espinosa A; Rincón-Cervera MÁ; Ortiz M; Hernandez-Rodas MC; Valenzuela A; Videla LA
Food Funct; 2017 Apr; 8(4):1526-1537. PubMed ID: 28386616
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous Administration of Dexamethasone and Vitamin E Reversed Experimental Varicocele-induced Impact in testicular tissue in Rats; Correlation with Hsp70-2 Chaperone Expression.
Khosravanian H; Razi M; Farokhi F; Khosravanian N
Int Braz J Urol; 2015; 41(4):773-90. PubMed ID: 26401872
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of combining pentoxiphylline and vitamin E versus vitamin E alone in non-alcoholic steatohepatitis- A randomized pilot study.
Kedarisetty CK; Bhardwaj A; Kumar G; Rastogi A; Bihari C; Kumar M; Sarin SK
Indian J Gastroenterol; 2021 Feb; 40(1):41-49. PubMed ID: 33772456
[TBL] [Abstract][Full Text] [Related]
16. Nutrigenetic Interactions Might Modulate the Antioxidant and Anti-Inflammatory Status in Mastiha-Supplemented Patients With NAFLD.
Kanoni S; Kumar S; Amerikanou C; Kurth MJ; Stathopoulou MG; Bourgeois S; Masson C; Kannt A; Cesarini L; Kontoe MS; Milanović M; Roig FJ; Beribaka M; Campolo J; Jiménez-Hernández N; Milošević N; Llorens C; Smyrnioudis I; Francino MP; Milić N; Kaliora AC; Trivella MG; Ruddock MW; Medić-Stojanoska M; Gastaldelli A; Lamont J; Deloukas P; Dedoussis GV; Visvikis-Siest S
Front Immunol; 2021; 12():683028. PubMed ID: 34025683
[TBL] [Abstract][Full Text] [Related]
17. Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis.
Awad AS; Abd Al Haleem EN; El-Bakly WM; Sherief MA
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):381-91. PubMed ID: 26753695
[TBL] [Abstract][Full Text] [Related]
18. Haptoglobin 2 Allele is Associated With Histologic Response to Vitamin E in Subjects With Nonalcoholic Steatohepatitis.
Banini BA; Cazanave SC; Yates KP; Asgharpour A; Vincent R; Mirshahi F; Le P; Contos MJ; Tonascia J; Chalasani NP; Kowdley KV; McCullough AJ; Behling CA; Schwimmer JB; Lavine JE; Sanyal AJ;
J Clin Gastroenterol; 2019; 53(10):750-758. PubMed ID: 30586008
[TBL] [Abstract][Full Text] [Related]
19. Association of pro-inflammatory cytokines, adipokines & oxidative stress with insulin resistance & non-alcoholic fatty liver disease.
Kumar R; Prakash S; Chhabra S; Singla V; Madan K; Gupta SD; Panda SK; Khanal S; Acharya SK
Indian J Med Res; 2012 Aug; 136(2):229-36. PubMed ID: 22960889
[TBL] [Abstract][Full Text] [Related]
20. Systematic review with meta-analysis: The effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease.
Vadarlis A; Antza C; Bakaloudi DR; Doundoulakis I; Kalopitas G; Samara M; Dardavessis T; Maris T; Chourdakis M
J Gastroenterol Hepatol; 2021 Feb; 36(2):311-319. PubMed ID: 32810309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
